<DOC>
	<DOCNO>NCT02555280</DOCNO>
	<brief_summary>A 2 5 year comparative evaluation clinical outcome treatment degenerative spinal stenosis concomitant low back pain decompression without additional stabilization use coflex® Interlaminar Technology FDA Real Conditions Use Study .</brief_summary>
	<brief_title>Post-Approval 'Real Conditions Use ' Study</brief_title>
	<detailed_description>The first objective trial evaluate 5-year clinical status patient implant coflex® device conjunction surgical decompression relative decompression alone . The composite primary endpoint objective three part : 1 ) At least 15 point improvement relative pretreatment baseline Oswestry Disability Index ( ODI , range 0-100 ) ; 2 ) No reoperations , revision , removal , supplemental fixation index level ( ) ; 3 ) No ≥2 injection series injection treat level , nerve block procedure perform treat spinal stenosis index level ( ) single injection within 12 month 5 year endpoint . The second objective study compare clinical status patient implant coflex® device conjunction surgical decompression relative surgical decompression alone two year post-operatively confirm clinical non-inferiority term Month 24 composite clinical success ( CCS ) define similarly investigational device exemption ( IDE ) study endpoint . Objective 3 : If non-inferiority show two-years , evaluate evidence support superiority two-years term Month 24 CCS use informative prior distribution coflex® group . Finally , fourth objective trial evaluate coflex® device performance 'real condition use ' study confirm coflex® device performance clinically inferior PAS population compare pivotal IDE trial population . The Month 24 composite clinical success ( CCS ) endpoint use IDE trial use analysis facilitate comparison .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<criteria>1 . Radiographic confirmation least moderate lumbar stenosis , narrow central spinal canal one two contiguous level L1L5 require surgical decompression . Moderate stenosis define &gt; 25 % reduction anteroposterior dimension compare next adjacent normal level , nerve root crowd compare normal level , determine investigator computerize tomography ( CT ) Scan MRI . The patient may , require inclusion study : Facet hypertrophy subarticular recess stenosis affect level ( ) ; Foraminal stenosis affect level ( ) ; Up stable Grade I degenerative spondylolisthesis ( Meyerding classification ) equivalent retrolisthesis determine flexion/extension X ray : ( ) For single level disease , may stable Grade I spondylolisthesis equivalent retrolisthesis affect level determine flexion/extension file investigator . ( ii ) For two level disease , may stable Grade I spondylolisthesis equivalent retrolisthesis ONLY ONE two contiguous affect level determine flexion/extension film investigator . Patients stable Grade I spondylolisthesis two contiguous level exclude , patient Grade I stable spondylolisthesis adjacent level may include . ( ) Mild lumbar scoliosis ( Cobb angle 25º ) 2 . Radiographic confirmation angular translatory instability spine index adjacent level ( instability define White &amp; Panjabi : Sagittal plane translation &gt; 4.5mm 15 % sagittal plane rotation &gt; 15° L1L2 , L2L3 , L3L4 ; &gt; 20° L4L5 base stand flexion/extension Xrays ) 3 . Visual Analog Scale back pain score least 50 mm 100 mm scale . 4 . Neurogenic claudication define leg/buttocks groin pain relieved flexion sit chair . 5 . Patient undergone least one epidural injection prior time point , AND least 6 month prior conservative care without adequate sustain symptom relief . 6 . Age 40 80 year . 7 . Oswestry Low Back Pain Disability Questionnaire score least 20/50 ( 40 % ) . 8 . Appropriate candidate treatment use posterior surgical approach . 9 . Psychosocially , mentally , physically able fully comply protocol , include adhere schedule visit , treatment plan , complete form , study procedure . 10 . Personally sign date informed consent document prior studyrelated procedure indicate patient inform pertinent aspect trial . 1 . More two contiguous vertebral level require surgical decompression . 2 . Prior surgical procedure result translatory instability lumbar spine [ define White &amp; Panjabi ( see 3.4.1 Inclusion Criteria , Item # 2 ) ] . 3 . More one surgical procedure combination lumbar level . 4 . Prior fusion , implantation total disc replacement , complete laminectomy , implantation interspinous process device index level . 5 . Radiographically compromised vertebral body lumbar level ( ) cause current past trauma tumor ( e.g. , compression fracture ) . 6 . Severe facet hypertrophy require extensive bone removal would cause instability . 7 . Isthmic spondylolisthesis spondylolysis ( pars fracture ) . 8 . Degenerative lumbar scoliosis ( Cobb angle great 25° ) . 9 . Disc herniation lumbar level require surgical intervention . 10 . Osteopenia : A screening questionnaire osteopenia , SCORE ( Simple Calculated Osteoporosis Risk Estimation ) , use screen patient require DEXA ( dualenergy xray absorptiometry ) bone mineral density measurement . If DEXA required* , exclusion define DEXA bone density measure T score ≤ 1.0 ( The World Health Organization definition osteopenia ) . 11 . Back leg pain unknown etiology . 12 . Axial back pain , leg , buttock , groin pain . 13 . Morbid obesity define body mass index &gt; 40 . 14 . Pregnant interested become pregnant next three year . 15 . Known allergy titanium , titanium alloy , MR ( magnetic resonance ) contrast agent . 16 . Active chronic infection systemic local . 17 . Chronically take medication drug know potentially interfere bone/soft tissue healing ( e.g. , steroid ) , include medrol dose pack . 18 . History significant peripheral neuropathy . 19 . Significant peripheral vascular disease ( e.g. , diminish dorsalis pedis posterior tibial pulse ) . 20 . Unremitting back pain position . 21 . Uncontrolled diabetes . 22 . Known history Paget 's disease , osteomalacia , metabolic bone disease ( exclude osteopenia , address ) . 23 . Cauda equina syndrome , defined neural compression cause neurogenic bowel ( rectal incontinence ) bladder ( bladder retention incontinence ) dysfunction . 24 . Fixed complete motor , sensory , reflex deficit . 25 . Rheumatoid arthritis autoimmune disease . 26 . Known documented history communicable disease , include AIDS , HIV , active Hepatitis 27 . Active malignancy : patient history invasive malignancy ( except nonmelanoma skin cancer ) , unless he/she treat curative intent clinical sign symptom malignancy least five year . Patients primary bony tumor exclude well . 28 . Prisoner ward state . 29 . Subject history substance abuse ( e.g. , recreational drug , narcotic , alcohol ) . 30 . Subject currently involve study another investigational product similar purpose . 31 . Currently seek receive workman 's compensation . 32 . In active spinal litigation .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>